ICM Advisors deals with the valuation experience of other identifiable intangibles assets such as: Proprietary know-how & Trade Secret, Copyrights, Industrial Design, R&D projects and Contract-Related intangibles (franchises, licensing agreements, construction permits, broadcast rights, and service or supply contracts).


Trade secrets are both valuable as patent alternatives and patent complementaries.

They are proprietary information, knowledge, formulas, methods, designs or processes.

What differentiates trade secrets from know-how is that they must present a commercial advantage, they are not commercially known or readily ascertainable, they are subject of efforts to keep such knowledge secret.

We have developed and practiced a specific methodology to valuate the Proprietary Know-how

KES© – (Know-how Equity Score).


Industrial design impacts on the brand value of many consumers and semidurable products such as automobiles, furniture, white goods, mobile phones, consumer electronics, tablets.


Through its DES© (Design Equity Score) methodology we valuate the economic and financial contribution of the Industrial Design to the Brand value.



In R&D there are cases when it may be favorable for an enterprise to collaborate with a company, university or some other organizations or consortia.


To successfully achieve R&D collaboration, the organization must manage many business processes, risks, controls and all the other issues involved. If an enterprise does not manage these issues, the collaboration may bring many drawbacks, including significant economic losses.


One of the key issues of Collaborative R&D is to valuate the potential IP Fall out and manage the ownership of the generated assets.


ICM has developed a significant know-how in working with industrial clusters that manage Collaborative R&D projects portfolio. To valuate R&D projects we have developed PES© (Project Equity Score) methodology that measures 27 elements in 5 areas: Probability of Technology success, Technology transferability level, Probability of commercial success, Business Impact, Forward IP.


In-process research and development is a complicated concept, that deserves a high level of attention from companies and investors.


In-process research and development (IPR&D) activities can have significant value and drive a

significant component of the acquisition price of companies, particularly in the software, technology, pharmaceutical and life sciences industries.


IPR&D refers to an intangible asset used in R&D activities and is distinguished from a tangible asset thatis used in R&D activities (e.g. laboratory equipment) or an intangible asset resulting from completed projects R&D.


We support companies and investors to understand the issues and rules relating to in-process research and development expenses in order have a sound valuation for investment decisions.